Jon P. Stonehouse

Jon P. Stonehouse, a pharmaceutical executive for more than 20 years, has strong commercialization, financial transaction, business development and management expertise. He most recently served as Senior Vice President of Corporate Development at Merck KGaA with responsibility for global licensing and business development, corporate mergers and acquisitions, corporate strategic planning and alliance management. Among his accomplishments, he was responsible for leading the effort to develop a strategy for Merck that significantly changed the company. This culminated with the acquisition of Serono, S.A., the largest biotechnology company in Europe at the time of the agreement.

Jon P. Stonehouse is the President & CEO at BioCryst Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Jon P. Stonehouse has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.